Showing results (441-450 of 2,686) with videos related to

Sort By:
Pageof 269
The Lancet. Infectious Diseases|November 12, 2021
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort studyMinggui Wang, Michelle Earley, Liang Chen, et al.
The Lancet. Infectious Diseases|March 21, 2021
Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling studySam Moore, Edward M Hill, Michael J Tildesley, et al.
The Lancet. Infectious Diseases|March 21, 2021
Nurses at the frontline of public health emergency preparedness and response: lessons learned from the HIV/AIDS pandemic and emerging infectious disease outbreaksVincent Guilamo-Ramos, Marco Thimm-Kaiser, Adam Benzekri, et al.
The Lancet. Infectious Diseases|March 7, 2021
Antibacterial mouthwash to prevent sexually transmitted infections in men who have sex with men taking HIV pre-exposure prophylaxis (PReGo): a randomised, placebo-controlled, crossover trialChristophe Van Dijck, Achilleas Tsoumanis, Anke Rotsaert, et al.
The Lancet. Infectious Diseases|January 30, 2021
Assessing the burden of congenital rubella syndrome in China and evaluating mitigation strategies: a metapopulation modelling studyQiru Su, Zhilan Feng, Lixin Hao, et al.
The Lancet. Infectious Diseases|November 28, 2021
Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case-control study and a mechanistic study of post-vaccination immune responsesRamachandran Thiruvengadam, Amit Awasthi, Guruprasad Medigeshi, et al.
The Lancet. Infectious Diseases|February 28, 2021
Risk predictors of progression to severe disease during the febrile phase of dengue: a systematic review and meta-analysisSorawat Sangkaew, Damien Ming, Adhiratha Boonyasiri, et al.
The Lancet. Infectious Diseases|November 29, 2021
Prevention of SARS-CoV-2 transmission during a large, live, indoor gathering (SPRING): a non-inferiority, randomised, controlled trialConstance Delaugerre, Frantz Foissac, Hendy Abdoul, et al.
The Lancet. Infectious Diseases|December 10, 2021
Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trialsGang Zeng, Qianhui Wu, Hongxing Pan, et al.
The Lancet. Infectious Diseases|December 24, 2021
The European clinical research response to optimise treatment of patients with COVID-19: lessons learned, future perspective, and recommendationsHerman Goossens, Lennie Derde, Peter Horby, et al.
Pageof 269